A brief history of familial Mediterranean fever

Marwan H. Adwan

Abstract


[No Abstract Available]

 

Saudi Med J 2015; Vol. 36 (9): 1126-1127
doi: 10.15537/smj.2015.9.12219


Full Text:

PDF HTML

References


Reimann HA. Periodic disease. Medicine 1951; 30: 3.

Heberden W. Commentaries on history and care of disease. London (UK): Wells and Lilly; 1802. p. 151.

Osler W. On the visceral manifestations of erythema multiforme. Am J Med Sci 1895; 110: 629.

Janeway TC, Mosenthal HO. An unusual paroxysmal syndrome, probably allied to recurrent vomiting, with a study of the nitrogen metabolism. Arch Intern Med 1908; 2: 214-225.

Siegal S. Benign paroxysmal peritonitis. Ann Intern Med 1945; 23: 1-21.

Reimann HA. Periodic disease. JAMA 1948; 136: 239-244.

Reimann HA. Perplexities of a periodic entity. JAMA 1964; 190: 241.

Cattan R, Mamou H. [14 Cases of periodic disease, 8 of which are complicated by kidney diseases]. Bull Mem Soc Med Hop Paris 1951; 67: 1104-1107.

Tuqan NA. Periodic disease: a clinicopathologic study. Ann Intern Med 1958; 49: 885-899.

Heller H, Sohar E, Sherf L. Familial Mediterranean fever. AMA Arch Intern Med 1958; 102: 50-71.

Daccak M. Periodic peritonitis, analysis of 19 cases. Diseases of the Colon & Rectum 1966; 9: 168-172.

Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell 1997; 90: 797-807.

French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997; 17: 25-31.

Hartung EF. History of the use of colchicum and related Medicaments in gout. Ann Rheum Dis 1954; 13: 190-200.

Goldfinger SE. Colchicine for familial Mediterranean fever. N Engl J Med 1972; 287: 1302.

Goldstein RC, Schwabe AD. Prophylactic colchicine therapy in familial Mediterranean fever. A controlled, double-blind study. Ann Intern Med 1974; 81: 792-794.

Zemer D, Revach M, Pras M, Modan B, Schor S, Sohar E, et al. A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N Engl J Med 1974; 291: 932-934.

Dinarello CA, Chusid MJ, Fauci AS, Gallin JI, Dale DC, Wolff SM. Effect of prophylactic colchicine therapy on leukocyte function in patients with familial Mediterranean fever. Arthritis Rheum 1976; 19: 618-622.

Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002; 10: 417-426.

Papin S, Cuenin S, Agostini L, Martinon F, Werner S, Beer HD, et al. The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ 2007; 14: 1457-1466.


Refbacks

  • There are currently no refbacks.




Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.